Literature DB >> 34291201

Near infrared light amplifies endothelial progenitor cell accumulation after stroke.

Andrew Vahabzadeh-Hagh1,2, Thomas J McCarthy3, Luis De Taboada4, Jackson Streeter5, Alvaro Pascual-Leone2, Eng H Lo1, Kazuhide Hayakawa1.   

Abstract

Damage-associated molecular pattern signals may play key roles in mediating non-cell autonomous effects of pre and post-conditioning. Here, we show that near-infrared (NIR) light stimulation of astrocytes increases a calcium-dependent secretion of the prototypical DAMP, HMGB1, which may then accelerate endothelial progenitor cell (EPC) accumulation after stroke. Conditioned media from NIR-stimulated astrocytes increased EPC proliferation in vitro, and blockade of HMGB1 with siRNA diminished the effect. In vivo transcranial NIR treatment confirmed that approximately 40% of NIR could penetrate the scalp and skull. Concomitantly, NIR increased GFAP expression in normal mouse brain at 30 min after the irradiation. In a mouse model of focal ischemia, repeated irradiation of NIR at days 5, 9, and 13 successfully increased HMGB1 in peri-infarct cortex, leading to a higher accumulation of EPCs at 14 days post-stroke. Conditioning and tolerance are now known to involve cell-cell signaling between all cell types in the neurovascular unit. Taken together, our proof-of-concept study suggest that NIR light may be an effective conditioning tool to stimulate astrocytic signaling and promote EPC accumulation after stroke.

Entities:  

Keywords:  Astrocytes; endothelial progenitor cells; near-infrared light; stroke

Year:  2019        PMID: 34291201      PMCID: PMC8291201     

Source DB:  PubMed          Journal:  Cond Med        ISSN: 2577-3240


  48 in total

Review 1.  Photobiology of low-power laser effects.

Authors:  T Karu
Journal:  Health Phys       Date:  1989-05       Impact factor: 1.316

Review 2.  Central nervous system injury-induced immune deficiency syndrome.

Authors:  Christian Meisel; Jan M Schwab; Konstantin Prass; Andreas Meisel; Ulrich Dirnagl
Journal:  Nat Rev Neurosci       Date:  2005-10       Impact factor: 34.870

Review 3.  The cytokine activity of HMGB1.

Authors:  Huan Yang; Haichao Wang; Christopher J Czura; Kevin J Tracey
Journal:  J Leukoc Biol       Date:  2005-02-25       Impact factor: 4.962

4.  Regulation of gene expression in ischemic preconditioning in the brain.

Authors:  Tuo Yang; Qianqian Li; Feng Zhang
Journal:  Cond Med       Date:  2017-12-15

Review 5.  Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research.

Authors:  Carol Kilkenny; William J Browne; Innes C Cuthill; Michael Emerson; Douglas G Altman
Journal:  PLoS Biol       Date:  2010-06-29       Impact factor: 8.029

Review 6.  Effect of experimental stroke on peripheral immunity: CNS ischemia induces profound immunosuppression.

Authors:  H Offner; A A Vandenbark; P D Hurn
Journal:  Neuroscience       Date:  2008-07-01       Impact factor: 3.590

Review 7.  Help-me signaling: Non-cell autonomous mechanisms of neuroprotection and neurorecovery.

Authors:  Changhong Xing; Eng H Lo
Journal:  Prog Neurobiol       Date:  2016-04-11       Impact factor: 11.685

8.  Delayed treatment with minocycline ameliorates neurologic impairment through activated microglia expressing a high-mobility group box1-inhibiting mechanism.

Authors:  Kazuhide Hayakawa; Kenichi Mishima; Masanori Nozako; Mai Hazekawa; Shohei Mishima; Masayuki Fujioka; Kensuke Orito; Nobuaki Egashira; Katsunori Iwasaki; Michihiro Fujiwara
Journal:  Stroke       Date:  2008-02-07       Impact factor: 7.914

Review 9.  A Role for Photobiomodulation in the Prevention of Myocardial Ischemic Reperfusion Injury: A Systematic Review and Potential Molecular Mechanisms.

Authors:  Ann Liebert; Andrew Krause; Neil Goonetilleke; Brian Bicknell; Hosen Kiat
Journal:  Sci Rep       Date:  2017-02-09       Impact factor: 4.379

Review 10.  Near-infrared photonic energy penetration: can infrared phototherapy effectively reach the human brain?

Authors:  Theodore A Henderson; Larry D Morries
Journal:  Neuropsychiatr Dis Treat       Date:  2015-08-21       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.